AliveCor QT Service vs AI-CVD
AI Verdict
Choose AliveCor QT Service if…
Choose AliveCor QT Service if you require immediate, precise QT and QTc interval measurements from 6-Lead ECGs to guide real-time medication prescribing decisions and monitor for cardiac safety. This cloud-based Software as a Medical Device (SaMD) is ideal for healthcare professionals who need to quickly assess the risk of drug-induced QT prolongation in a clinical setting, streamlining the process of prescribing QT-prolonging medications.
View AliveCor QT Service →Choose AI-CVD if…
Choose AI-CVD if your objective is opportunistic screening for a wide range of cardiovascular and multisystem diseases using existing chest and abdominal CT scans. This AI-powered platform is best suited for identifying hidden health risks and disease markers without requiring additional imaging, radiation, contrast, or disruption to patient workflow, leveraging millions of already acquired CT scans for early detection and prevention.
View AI-CVD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AliveCor QT Service | AI-CVD |
|---|---|---|
| Pricing | Varies by product and service, with subscription options available. | Unknown |
| Deployment | Mobile app, cloud-based platform, EHR integration. | Unknown |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AliveCor QT ServiceAliveCor QT Service integrates with the user-friendly KardiaPro portal and KardiaStation app, providing instant measurements to streamline workflow for healthcare professionals. Patients can also successfully record mECGs after basic instructions, indicating a direct and accessible user experience.
Clinical Value
AI-CVDAI-CVD offers a broader and more comprehensive clinical value by performing opportunistic screening for a wide array of cardiovascular and multisystem diseases from existing CT scans. This enables early detection of hidden health risks and can predict various adverse outcomes, representing a significant paradigm shift in preventive imaging.
Pricing & Value
TieBoth AliveCor QT Service and AI-CVD require contacting the vendor directly for pricing details, with no public information disclosed. Without transparent pricing, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value propositions.
Enterprise Readiness
AliveCor QT ServiceAliveCor QT Service explicitly states HIPAA compliance and having a Business Associate Agreement (BAA), and offers a comprehensive API for integration with various enterprise systems like EHR, SDK, and CRM. While AI-CVD is FDA cleared and cloud-based, its BAA and HIPAA compliance are noted as 'likely, contact vendor,' which is less definitive.
Innovation
AI-CVDAI-CVD demonstrates a higher degree of innovation by transforming existing CT scans into a comprehensive, multi-disease opportunistic screening platform without requiring additional imaging or workflow disruption. This approach leverages previously underutilized data for early detection across a broad spectrum of conditions, marking it as the 'most comprehensive FDA-cleared opportunistic screening platform.'
Support & Docs
AliveCor QT ServiceAliveCor QT Service benefits from AliveCor's established 'Resource Hub' which includes educational materials, study summaries, and clear contact options for support. While HeartLung.AI mentions a 'Knowledge Center' and 'Resources,' the available information does not detail the breadth or accessibility of its support and documentation to the same extent.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AliveCor QT Service | AI-CVD |
|---|---|---|
| Tool Name | AliveCor QT Service | AI-CVD |
| Company | AliveCor | HeartLung Corporation |
| Primary Purpose | Provides instant, accurate QT and QTc interval measurements for cardiac safety assessment and informed medication prescribing decisions. | Performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans for early detection of hidden health risks. |
| Input Data Source | AliveCor 6-Lead ECGs | Existing chest and abdominal CT scans |
| Key Analytical Focus | Measures QT and QTc intervals (Bazett's and Fridericia's formulas) using AI and deep neural networks. | Automated CT-derived anatomical and density-based measurements, including Coronary Artery Calcium (CAC) scoring, cardiac chamber volumetry, and epicardial fat volumetry. |
| Specialties Supported | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring AliveCor QT Service and AI-CVD.
Frequently Asked Questions
More Comparisons
More matchups featuring AliveCor QT Service or AI-CVD
Backers
Who funded each tool's parent company.